Navigation Links
Catheter Ablation Effective in Treating Atrial Fibrillation
Date:5/14/2009

Burning faulty tissue better than meds for irregular heartbeat, study suggests

THURSDAY, May 14 (HealthDay News) -- Treating an irregular heartbeat by searing faulty heart tissue may be more effective than treating with medication, a new study shows.

Nearly two-thirds of study participants with atrial fibrillation experienced no such condition-related symptoms one year after having a catheter ablation, a procedure in which heart tissue responsible for the erratic electrical signals throwing off the organ's pumping rhythm is burned and destroyed. Only 17 percent of those in the study treated for the condition with medications reported being arrhythmia-free in the same period.

Those who had the surgical procedure also said they experienced a great improvement in their quality of life.

The international study's 167 participants, all of whom had previously been unable to control the condition with medication alone, had been randomly assigned to either have the heart procedure or be treated for it with medications, according to the research, lead by Dr. David Wilber, director of the Cardiovascular Institute at Loyola University Stritch School of Medicine, in Maywood, Ill.

Wilber was scheduled to present his team's findings Thursday at the Heart Rhythm Society's annual meeting in Boston. The study was funded by Biosense Webster, maker of the ThermoCool catheter used in the trial, and Wilber is a consultant to the company.

More than 2 million Americans have atrial fibrillation, making it the most common of heart rhythm disorders. The electrical signals to the heart become irregular, causing the organ's upper chambers to pump out of rhythm. The condition can cause heart palpitations, dizziness, fatigue, shortness of breath and fainting that lead to a person having a lack of energy, feeling of weakness and a poor quality of life. It can also lead to stroke and heart failure.

Doctors often first prescribe beta blockers, calcium channel blockers, flecainide or propafenone to try to improve the condition before resorting to surgical options such as installing a pacemaker or catheter ablation.

In catheter ablation, doctors guide a thin flexible tube through blood vessels to the heart. Radiofrequency energy directed from the tube's tip heats and destroys the tissue causing the bad electrical signals. The procedure's risks include creating fluid in the lungs or around the heart, bleeding, clots and stroke.

Another study, involving about 3,000 atrial fibrillation patients who will be followed for three years, will try to determine whether those who have catheter ablation live longer those using medication for the condition, according to background information in a Loyola University news release on the study.

More information

The American Heart Association has more about atrial fibrillation.



-- Kevin McKeever



SOURCE: Loyola University Health System, news release, May 14, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
2. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
3. Catheter angiography may be an unnecessary follow-up to CT angiography
4. Massive necrosis after trans-catheter treatment is more common in the presence of tumor capsule
5. Catheter chaos: Hospitals lag in preventing common infection
6. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
7. Balloon catheter-based sinus surgery radiation exposure very low, safe
8. St. Davids Medical Center First in Texas to Implement Visually Guided Catheter Ablation for Atrial Fibrillation
9. Led by Cardiovascular Applications, Double Digit Growth Expected for Catheter Sales
10. Catheter repair of mitral valve improves heart size, symptoms
11. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Catheter Ablation Effective in Treating Atrial Fibrillation
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... and Strategies - 2016" report to their offering. ... The latest research Autism ... pricing data and benchmarks in the global Autism Spectrum Disorder market. ... What are the key drugs marketed for Autism Spectrum Disorder ...
(Date:2/23/2017)... 2017 ITL Limited, ( ASX: ITD ), an innovative ... half year ended 31 December 2016 compared with the previous corresponding ... be viewed here . Highlights ... 104%) Earnings per share of 2.2 cents (Dec ... (Dec 2015: $15.7m; up 11%) Profit before tax ...
(Date:2/23/2017)... , Feb 23, 2017 Research and ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... drug pricing data and benchmarks in the global Oesophageal Cancer market. ... What are the key drugs marketed for Oesophageal Cancer ...
Breaking Medicine Technology: